Prevention and Treatment of Cryptococcal Meningitis
A special issue of Journal of Fungi (ISSN 2309-608X). This special issue belongs to the section "Fungal Pathogenesis and Disease Control".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 178
Special Issue Editor
Special Issue Information
Dear Colleagues,
The global burden of cryptococcal meningitis (CM) remains unacceptably high. HIV-associated CM claims over 100,000 lives every year and accounts for around 20% of all HIV-related deaths. Furthermore, cases are not decreasing in most African countries due to continued late presentation of patients with HIV infection, and patients falling out of care and interrupting antiretroviral therapy. Furthermore, non-HIV CM cases are now the majority in many developed country settings, and there are few recent studies to guide best practice in this heterogeneous group, for whom treatment is often very challenging.
For this issue, we invite reviews and research articles that add to and review the evidence base for current guidelines and practice and ongoing implementation efforts; studies to optimise the cryptococcal antigen screen and presumptive treatment strategy to prevent HIV-associated CM; and promising new evidence and avenues that could help reduce the global burden of both HIV-associated and non-HIV-associated cryptococcal infection.
Dr. Thomas S. Harrison
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Fungi is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cryptococcal meningitis
- cryptococcal antigen
- screening antifungals
- amphotericin
- fluconazole
- flucytosine
- liposomal amphotericin
- HIV-associated
- non-HIV-associated intracranial pressure
- immune reconstitution
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
